Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: An open-label, pilot clinical trial Academic Article uri icon

Overview

MeSH Major

  • Pyrimidines
  • Scleroderma, Diffuse
  • Skin
  • Transcriptome

abstract

  • Clinicaltrials.gov NCT01166139 , July 1, 2010.

publication date

  • August 18, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4538758

Digital Object Identifier (DOI)

  • 10.1186/s13075-015-0721-3

PubMed ID

  • 26283632

Additional Document Info

start page

  • 213

volume

  • 17

number

  • 1